Therapy Market Research Reports & Industry Analysis

... online work with the project data to print or export an individual report. Although there are only two approved and marketed RNA based ... CpG Oligonucleotides Corporate Clinical Stage RNA Therapeutics R&D Pipelines About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but ...

... aminopeptidase 2 (MetAP2) Inhibitors f) Other Metabolic Modifiers 6) Various Approaches 7) Unspecified Targets Corporate Targeted Therapy of Obesity R&D Pipelines About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D ...

... (RNAi) or Locked Nucleic Acid (LNA) RNA. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of ... illustrate the database. Purchase of the subscription provides a 1-year online access to the data of the RNA Therapeutics Pipeline Database. Credentials to access ...

The global radiation therapy market has witnessed a double digit growth rate during the last ... from developing nations. The report provides an in-depth analysis of the global radiation therapy market. The various drivers, opportunities and the challenges faced by the ...

This report analyzes the Global market for Narcolepsy Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 ... , Inc., Cephalon, Inc., Evotec AG, Hypnion, Inc., and Jazz Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. ...

This report analyzes the worldwide markets for ADHD Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US and ... , Novartis AG, Shire Plc, UCB S.A., Companies with Drugs in Pipeline for ADHD: Abbott Laboratories, Inc., Cortex Pharmaceuticals, Inc., KemPharm, Inc., and ...

This report analyzes the Global market for Inflammatory Bowel Disease Therapeutics in US$ Million. Annual estimates and forecasts are provided for the ... Pharmaceutical Co.Ltd., Prometheus Laboratories, Inc., Shire plc, UCB SA, and Wyeth. Market data and analytics are derived from primary and secondary ...

This report analyzes the Global market for Tuberculosis Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 ... SA, Summit Plc, Tibotec BVBA, Otsuka Pharmaceutical Co., Ltd., and Sequella, Inc. Market data and analytics are derived from primary and secondary research. ...

This report analyzes the worldwide markets for Multiple Sclerosis Therapeutics in US$ Billion. The report provides separate comprehensive analytics for the US, Japan, Europe and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report profiles ...

This report analyzes the worldwide markets for Melanoma Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, and Rest of ... through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 73 companies including many key and niche players ...

This report analyzes the worldwide markets for Dyslipidemia Therapeutics in US$ Million by the following segments - Statins, and Non-Statins. The report provides ... Mylan, Inc., Novartis AG, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Lymphoma Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Europe, and ... ., ImmunoGen, Inc., InNexus Biotechnology, Inc., and Millennium Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary ...

... a hyperlink leading to the source of information. Index Proteins & peptides Antibodies Vaccines Corporate R&D Pipelines of Biologic and Immuno Therapeutics of S. aureus infections About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS, but concise ...

This report analyzes the worldwide markets for Rheumatoid Arthritis Therapeutics in US$ Million.The report provides separate comprehensive analytics for US, Japan, ... Johnson & Johnson Services, Inc., Schering-Plough Corp., UCB S.A., and Wyeth. Market data and analytics are derived from primary and secondary ...

... targeted therapy of prostate and other cancers. Prostate-specific antigen (PSA) was discovered more than 20 years ago and has become the ... PSA Targeted Therapy Corporate PSMA & PSA Targeted Therapy R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers ...

... . The global market for autoimmune disease treatments is estimated to be at $37.84 billion in 2009, and is growing at a CAGR of 12.7% from 2009 to 2014 to reach an estimated $68.81 billion in 2014. The effects of the global ... 2009 to 2014. Scope of the Report The report provides market overviews and forecasts as well as market drivers and restraints for the global autoimmune treatment ...

... globally. The dialysis care market has seen major growth in the last few years and in this segment – the most preferred method of treatment continues to be hemodialysis ...

... proton therapy market. Key Highlights of the United States Proton Therapy Market Report: Proton Therapy Current Applications Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy Proton Therapy Competitive Analysis: By Company Market Size & Analysis: United States Proton Therapy ...

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. This report will be delivered in 7-10 workin...

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. This report will be delivered in 1-5 working...